Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats

Digestive Diseases and Sciences

Volumn 52, Issue 3, 2007, Pages 612-619

  Mauger, Chad A ^a,b   Butler, Ross N ^a,c   Geier, Mark S ^a,c   Tooley, Katie L ^a,c   Howarth, Gordon S ^a,b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

5 Fluorouracil; Bifidobacterium; Lactobacillus; Mucositis; Probiotic; Sucrose breath test

Indexed keywords

CARBON DIOXIDE; FLUOROURACIL; PROBIOTIC AGENT; SODIUM CHLORIDE; SUCRASE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INTESTINE INJURY; INTESTINE MUCOSA; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MILK; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SMALL INTESTINE; STATISTICAL SIGNIFICANCE;

ANIMALS; BIFIDOBACTERIUM; BREATH TESTS; DISEASE MODELS, ANIMAL; FEMALE; FLUOROURACIL; ILEUM; IMMUNOSUPPRESSIVE AGENTS; JEJUNUM; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; PEROXIDASE; PROBIOTICS; RATS; RATS, INBRED STRAINS; STOMATITIS; SUCRASE;

EID: 33847229128     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9464-y     Document Type: Article

References (40)

1. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett Jr WH, Mulagha MT, Peterson DE, Rose AH, Schubert MM, Spijkervet FK, et al. (1999) Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 85:2103-2113
2. Pico J-L, Avila-Garavito A, Naccache P (1998) Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 3:446-451
3. Khan SA, Wingard JR (2001) Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr 31-36
4. Keefe DMK (2004) Gastrointestinal mucositis: a new biological model. Support Care Cancer 12:6-9
5. Clarke J, Butler R, Howarth G, Read L, Regester G (2002) Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster. Oral Oncol 38:478-485
6. Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2:21-32; discussion 35-36
7. Freytes CO, Ratanatharathorn V, Taylor C, Abboud C, Chesser N, Restrepo A, Arango J, Odenheimer D (2004) Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation. Clin Cancer Res 10:8318-8324
8. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, et al. (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590-2598
9. Howarth GS (2003) Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implications. J Nutr 133:2109-2112
10. Howarth GS, Francis GL, Cool JC, Xu X, Byard RW, Read LC (1996) Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 126:2519-2530
11. Harsha WT, Kalandarova E, McNutt P, Irwin R, Noel J (2006) Nutritional supplementation with transforming growth factor-beta, glutamine, and short chain fatty acids minimizes methotrexate-induced injury. J Pediatr Gastroenterol Nutr 42:53-58
12. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, et al. (2005) Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128:541-551
13. Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73:1142S-1146S
14. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531-536
15. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance-murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591
16. Park SY, Ji GE, Ko YT, Jung HK, Ustunol Z, Pestka JJ (1999) Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates. Int J Food Microbiol 46:231-241
17. Bezkorovainy A (2001) Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 73:S399-S405
18. Ruiz PA, Hoffmann M, Szency S, Blaut M, Haller D (2005) Innate mechanisms of Bifidobacterium lactis to activate transient pro-inflammatory host response in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115:441-450
19. Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, Kilk A (2002) Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 72:215-224
20. Hung J, Cooper D, Turner MS, Walsh T, Giffard PM (2003) Cystine up take prevents production of hydrogen peroxide by Lactobacillus fermentum BR11. FEMS Microbiol Lett 69:5855-5863
21. Rush CM, Hafner LM, Timms P (1994) Genetic modification of a vaginal strain of Lactobacillus fermentum and its maintenance within the reproductive tract after intravaginal administration. J Med Microbiol 41:272-278
22. Geier MS, Butler RN, Howarth GS (2005) Differential efficacy of probiotic species in amelioration of dextran sulphate sodium-induced colitis in rats. Gastroenterology 128:A603-A604
23. Pelton NS, Tivey DR, Howarth GS, Davidson GP, Butler RN (2004) A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol 39:1015-1016
24. Semenza G, Dahlqvist A (1985) Disaccharides of small-intestinal mucosa. J Pediatr Gastroenterol Nutr 4:857-867
25. Clarke JM, Pelton NC, Bajka BH, Howarth GS, Read LC, Butler RN (2006) Use of the (13)c-sucrose breath test to assess chemotherapy-induced small intestinal mucositis in the rat. Cancer Biol Ther 5:34-38
26. McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484-490
27. Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gargosky SE, Bllard FJ (1991) Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. J Endocrinol 128:97-105
28. Xian CJ, Howarth GS, Cool JC, Foster BK (2004) Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pre-treament on growth plate cartilage and metaphyseal bone in rats. Bone 35:739-749
29. Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, Howarth GS (2005) Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res 15:72-82
30. Dahlqvist A (1968) Assay of intestinal disaccharides. Anal Biochem 22:99-107
31. Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344-1350
32. Geier MS, Tenikoff D, Yazbeck R, McCaughan GW, Abbott CA, Howarth GS (2005) Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV. J Cell Physiol 204:687-692
33. Howarth GS, Xian CJ, Read LC (2000) Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth Factors 18:119-133
34. Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflammatory Bowel Dis 8:399-406
35. Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52:370-376
36. Di Stefano M, Miceli E, Armellini E, Missanelli A, Corazza GR (2004) Probiotics and functional abdominal bloating. J Clin Gastroenterol 38:S102-S103
37. Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R (2005) A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 22:387-394
38. Hawrelak JA, Whitten DL, Myers SP (2005) Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion 72:51-56
39. Myllyluoma E, Veijola L, Ahlroos T, Tynkkynen S, Kankuri E, Vapaatalo H, Rautelin H, Korpela R (2005) Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 21:1263-1272
40. Tooley K, Howarth G, Lymn K, Lawrence A, Butler R (2006) Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Ther 5(6):593-600